Meditech E-Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 2477.59%
(FY 2022)
- Profit 233.29%
(FY 2022)
- Ebitda 222.52%
(FY 2022)
- Net Worth 86.11%
(FY 2022)
- Total Assets -50.44%
(FY 2022)
About Meditech E-Labs
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Minakshi Dixit and Sanjeev Mishra serve as directors at the Company.
- CIN/LLPIN
U33111UP2016PTC076371
- Company No.
076371
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Meditech E-Labs Private Limited offer?
Meditech E-Labs Private Limited offers a wide range of products and services, including Industrial Air Conditioner & Devices, Air Damper, Oxygen & Nitrogen Gas Plants, Cylinder Filling Plants, Forceps & Graspers, Electrosurgical Unit, Vinyl, Plastic & Rubber Floor Tiles, Commercial & Domestic Floorings, Diagnostic Medical Imaging Equipment, X Ray Machine Parts.
Who are the key members and board of directors at Meditech E-Labs?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Minakshi Dixit | Director | 10-Apr-2019 | Current |
Sanjeev Mishra | Director | 09-Feb-2016 | Current |
Financial Performance of Meditech E-Labs.
Meditech E-Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2477.59% increase. The company also saw a substantial improvement in profitability, with a 233.29% increase in profit. The company's net worth Soared by an impressive increase of 86.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Meditech E-Labs?
In 2017, Meditech E-Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meditech E-Labs?
Unlock and access historical data on people associated with Meditech E-Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditech E-Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditech E-Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.